Clinical Trials Browser

Colorectal Neoplasms

Hemorrhage, Colorectal Neoplasms

Advanced Microsatellite Stable Colorectal Cancer

Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma

Carcinoma, Hepatocellular

Colorectal Neoplasms

Stomach Neoplasms

Brain Neoplasms

Colorectal Neoplasms

Uterine Cervical Neoplasms

Carcinoma, Hepatocellular

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

Ras-mutated Metastatic Colorectal Cancer

Advanced Gynecological Malignancies

Colorectal Neoplasms

Lung Diseases, Interstitial

Diabetes Mellitus, Insulin-Dependent, 12, Adenocarcinoma of Lung

Carcinoma, Hepatocellular

Colorectal Neoplasms

Colorectal Neoplasms

Rectal Neoplasms Malignant

Colorectal Neoplasms

Ovarian Neoplasms

Colorectal Neoplasms

Clinical Trials

BEST

An Observational Study to Learn About the Medicine - BEVACIZUMAB BS [Pfizer] in Colorectal Cancer Patients From Japan.

Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer

Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy

Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/Gastroesophageal Junction Adenocarcinoma

A Phase II Clinical Study of Utidelone and Bevacizumab With or Without Etoposide in Patients With Brain Metastases From Malignant Solid Tumors

Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer

JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer

MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)

SYS6090 Combination Therapy in Advanced Lung Cancer

A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer

QLS5132 Combination Therapy in Advanced Solid Tumors

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

A Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors

ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

PHOENIX

A Clinical Study of SH006 Injection in Combination Therapy Versus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma

A Clinical Study on the Treatment of Metastatic Colorectal Cancer at the Second-line or Beyond.

LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS Mutation

CAPOX and Bevacizumab With or Without Primary Tumor Radiotherapy and Iparomlimab and Tuvonralimab as First-line Treatment for RAS-Mutant/MSS Metastatic Rectal Cancer

ROMANCE - GOIM

To Evaluate the Efficacy and Safety of JPI-547 in Combination With Bevacizumab as Maintenance Therapy in Relapsed Ovarian Cancer

IBI363 Plus Bevacizumab With or Without Nab-Paclitaxel for Second-Line Treatment of Advanced Gastric Cancer

Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer Patients

COLIBRI-GI